Survivorship research established investigator award

描述（由申请人提供）：该资助的具体目的是指导年轻的临床研究者，主要在与癌症引起的症状控制和/或癌症治疗相关的研究领域。在调查员的职业生涯中，会有这样一个时刻：以前的导师变成了导师。虽然可能不太容易承认，但在我职业生涯的一半多时间里，我已经完成了从主要接受指导到成为导师的转变。现任中北部癌症治疗组（NCCTG）癌症控制项目主任，梅奥诊所综合癌症中心癌症预防与控制项目联合主任。十多年来，我一直是社区临床肿瘤学项目（CCOP）研究基地的首席研究员，并在过去获得了R01资助。通过这一努力，我可以说是开发了世界上最有成效的项目，旨在评估减轻癌症和/或癌症治疗引起的症状的方法。利用这一背景，我将利用这笔资金为有兴趣从事与缓解癌症症状和/或癌症治疗相关的临床研究的年轻临床研究者提供指导。我将使用“在职”培训方法来帮助他们开发适用的协议。我将指导他们完成方案审查过程，临床试验的实施，以及以科学摘要和手稿的形式报告结果的过程。我将帮助他们领导梅奥肿瘤症状控制项目。我会协助他们发展独立拨款。我认为这是一个继任计划的过程，希望这些被指导的个人中有一个或多个最终会接替我的位置，继续传播我们在梅奥诊所的症状控制研究项目，让他们指导下一代的研究人员。作为一名导师，我可以把我在早期职业生涯中获得的一些指导成果回馈给科学领域。这应该允许继续研究减轻与癌症和/或癌症治疗相关的症状的有希望的方法。这将改善对癌症患者的护理。

DESCRIPTION (provided by applicant): The specific aim of this grant is to mentor young clinical investigators, primarily in the area of research related to the control of symptoms caused by cancer and/or cancer therapy. A time comes in an investigator's career when a previously mentored person becomes the mentor. Although it might not be easy to admit, being more than half way through my career, I have made the transformation from primarily being mentored, to being a mentor. I am currently the Director of the Cancer Control Program of the North Central Cancer Treatment Group (NCCTG) as well as the co-director of the Cancer Prevention and Control Program of the Mayo Clinic Comprehensive Cancer Center. I have been the Principal Investigator of a community clinical oncology program (CCOP) research base grant for over a decade and have received R01 grant funding in the past. Through this effort, I have, arguably, developed the most productive program in the world designed to evaluate means of alleviating symptoms caused by cancer and/or cancer therapy. Using this background, with the funds obtained from this grant I will provide mentorship for young clinical investigators interested in a career in clinical research related to relief of symptoms from cancer and/or cancer therapy. I will use an "on-the-job" training approach to help them with the development of applicable protocols. I will mentor them through the protocol review process, through the conduct of clinical trials, and through the process to report results as scientific abstracts and manuscripts. I will facilitate their leadership of subsections of the Mayo Oncology Symptom Control Program. I will facilitate their development of independent grant funding. I view this as a process of succession planning, expecting that one or more of these mentored individuals will eventually take my place and continue to promulgate the symptom control research program that we have at Mayo Clinic, allowing them to mentor the next generation of investigators. This role as a mentor allows me to give back to the scientific field some of the fruits from the mentoring that was provided to me in my early career. This should allow for continued investigation for promising means for alleviating symptoms related to cancer and/or cancer therapy. This will improve the care of patients with cancer.